This investigation compound was 1st claimed by Hoffman-La Roche in 2009. It’s certainly one of numerous benzodiazepines within the imidazobenzodiazepine subgroup thought to provide nootropic benefits. Unfortunately, there isn’t A lot official investigation on this compound as the drug in no way made it to market place. Tarawneh et al. https://carlosf747rat9.topbloghub.com/profile